Variant NM_000492.4:c.1682C>A


Variant details:
Name NM_000492.4:c.1682C>A
Protein name NP_000483.3:p.(Ala561Glu)
Genomic name (hg19) chr7:g.117230409C>A    UCSC    
#Exon/intron exon 13
Legacy Name A561E
Class disease-causing
Subclass CF-causing
WT sequence TTTAATTTCCATTTTCTTTTTAGAG C AGTATACAAAGATGCTGATTTGTAT
Mutant sequence TTTAATTTCCATTTTCTTTTTAGAG A AGTATACAAAGATGCTGATTTGTAT

Other databases:
dbSNP
rs121909047



Pathogenicity predictors:

Functional studies:


Reference PMID Splicing mRNA level Maturation Localization Channel fonction (Cl-) Bicarbonate
Mendes et al, 2003 14623323 ✓ ✓ ✓
Roxo-Rosa et al, 2006 17098864 ✓ ✓
Van Goor et al, 2014 23891399 ✓ ✓ ✓


« ✓ » indicates the type of analysis performed and not the results




No patient found in CFTR-NGS catalogue


1 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 1
CF 1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare